Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Michael Guenther

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Future Oncology (London, England)|March 13, 2026
The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trialTimothy Beard, J Michael Guenther, Stanley P Leong, et al.
Cancer Medicine|April 1, 2025
A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEPJ Michael Guenther, Andrew Ward, Brian J Martin, et al.
Journal of Surgical Oncology|June 3, 2015
The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ resultMichael Alvarado, Dennis L Carter, J Michael Guenther, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
JCO Precision Oncology|September 27, 2021
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis PredictionEric D Whitman, Vadim P Koshenkov, Brian R Gastman, et al.
Annals of Surgical Oncology|October 6, 2016
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In SituJennifer B Manders, Henry M Kuerer, Benjamin D Smith, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Future Oncology (London, England)|March 13, 2026
The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trialTimothy Beard, J Michael Guenther, Stanley P Leong, et al.
Cancer Medicine|April 1, 2025
A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEPJ Michael Guenther, Andrew Ward, Brian J Martin, et al.
Journal of Surgical Oncology|June 3, 2015
The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ resultMichael Alvarado, Dennis L Carter, J Michael Guenther, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2017
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J Ellis, Vera J Suman, Jeremy Hoog, et al.
JCO Precision Oncology|September 27, 2021
Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis PredictionEric D Whitman, Vadim P Koshenkov, Brian R Gastman, et al.
Annals of Surgical Oncology|October 6, 2016
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In SituJennifer B Manders, Henry M Kuerer, Benjamin D Smith, et al.
Pageof 2